Donald Trump Alex Azar


Hope everyone had a restful 4th! I spent the weekend at a friend’s lake with my dog who loves to swim (he’s been very sleepy this week).

With the benefit of a day or two off, the Business Insider healthcare team was ready to hit the ground running with all the news that came our way this week: from kidney initiatives coming out of Washington, to Nurx’s launch of STD kits, to an HIV drug’s move into late-stage trials, and of course the nixed rebate rule plans also coming from our nation’s capital. More on that in a few.

But first, are you new to our newsletter? You can sign up for Dispensed here.

First up, the biggest news we were tracking this week was the layoffs at microbiome-testing company uBiome. We’ve been chronicling the troubles at the company for a few months now, since an FBI raid of the company’s headquarters in late April.

On Wednesday, the new executives heading the company let half of its 229 employees go, a significant chunk of which were a part of the company’s Latin America operations.

Erin Brodwin was there on the scene to hear reactions …read more

Source:: Businessinsider – Finance


(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *